1
|
Izrael R, Marton L, Nagy GN, Pálinkás HL, Kucsma N, Vértessy BG. Identification of a nuclear localization signal in the Plasmodium falciparum CTP: phosphocholine cytidylyltransferase enzyme. Sci Rep 2020; 10:19739. [PMID: 33184408 PMCID: PMC7665022 DOI: 10.1038/s41598-020-76829-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/04/2020] [Accepted: 11/02/2020] [Indexed: 12/30/2022] Open
Abstract
The phospholipid biosynthesis of the malaria parasite, Plasmodium falciparum is a key process for its survival and its inhibition is a validated antimalarial therapeutic approach. The second and rate-limiting step of the de novo phosphatidylcholine biosynthesis is catalysed by CTP: phosphocholine cytidylyltransferase (PfCCT), which has a key regulatory function within the pathway. Here, we investigate the functional impact of the key structural differences and their respective role in the structurally unique pseudo-heterodimer PfCCT protein in a heterologous cellular context using the thermosensitive CCT-mutant CHO-MT58 cell line. We found that a Plasmodium-specific lysine-rich insertion within the catalytic domain of PfCCT acts as a nuclear localization signal and its deletion decreases the nuclear propensity of the protein in the model cell line. We further showed that the putative membrane-binding domain also affected the nuclear localization of the protein. Moreover, activation of phosphatidylcholine biosynthesis by phospholipase C treatment induces the partial nuclear-to-cytoplasmic translocation of PfCCT. We additionally investigated the cellular function of several PfCCT truncated constructs in a CHO-MT58 based rescue assay. In absence of the endogenous CCT activity we observed that truncated constructs lacking the lysine-rich insertion, or the membrane-binding domain provided similar cell survival ratio as the full length PfCCT protein.
Collapse
Affiliation(s)
- Richard Izrael
- Institute of Enzymology, Research Centre for Natural Sciences, 1117, Budapest, Hungary.
- Doctoral School of Multidisciplinary Medical Sciences, University of Szeged, 6720, Szeged, Hungary.
- Department of Applied Biotechnology, Budapest University of Technology and Economics, 1111, Budapest, Hungary.
| | - Lívia Marton
- Institute of Enzymology, Research Centre for Natural Sciences, 1117, Budapest, Hungary
| | - Gergely N Nagy
- Institute of Enzymology, Research Centre for Natural Sciences, 1117, Budapest, Hungary
- Department of Applied Biotechnology, Budapest University of Technology and Economics, 1111, Budapest, Hungary
- Division of Structural Biology, Wellcome Centre for Human Genetics, University of Oxford, Oxford, OX3 7BN, UK
| | - Hajnalka L Pálinkás
- Institute of Enzymology, Research Centre for Natural Sciences, 1117, Budapest, Hungary
- Doctoral School of Multidisciplinary Medical Sciences, University of Szeged, 6720, Szeged, Hungary
- Department of Applied Biotechnology, Budapest University of Technology and Economics, 1111, Budapest, Hungary
| | - Nóra Kucsma
- Institute of Enzymology, Research Centre for Natural Sciences, 1117, Budapest, Hungary
| | - Beáta G Vértessy
- Institute of Enzymology, Research Centre for Natural Sciences, 1117, Budapest, Hungary.
- Department of Applied Biotechnology, Budapest University of Technology and Economics, 1111, Budapest, Hungary.
| |
Collapse
|